Oral supplementation has shown effectiveness but may not match the efficacy of IM in certain scenarios
Bioavailability approaches 8095% with subcutaneous delivery, compared to less than 10% with non-encapsulated oral dosing
GIP, like GLP-1, stimulates insulin secretion secondary to hyperglycaemia and additional, increases sensitivity of adipose tissue to insulin [2]
[ 4 ] Due to these concerns, at present, DSIP remains an experimental compound with ongoing debate regarding its physiological significance
medications is that most of the weight lost will be muscle mass
"It might still be getting signals to be like how he was on a GLP-1." A spokesperson for semaglutide manufacturer Novo Nordisk noted that there are "numerous studies" exploring the association between using the drugs and reductions in behaviors sometimes linked to addiction